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Abstract
In order to provide a statistically based evaluation of the incidence of invasive aspergillosis (IA) over time, we applied the cumulative
sums (CUSUM) methodology, which was developed for quality control and has already been applied for the surveillance of hospital-
acquired infections. Cases of IA were recorded during a 5-year period. Incidence rates of cases assumed to be hospital-acquired, i.e.
nosocomial IA (NIA), were analysed using CUSUM tests. Relationships between NIA, fungal contamination and construction or reno-
vation work were tested using time-series methods. Between January 2002 and December 2006, 81 cases of NIA were recorded.
CUSUM analysis of NIA incidence showed no signiﬁcant deviation from the expected monthly number of cases until August 2005,
and then the CUSUM crossed the decision limit, i.e. identiﬁed a signiﬁcant increase in NIA as compared with the reference period
(January 2002 to December 2004). Up to April 2006, the learning-curve CUSUM stayed over its limit, supporting an ongoing out-
break involving 24 patients, and then it signiﬁcantly decreased in May 2006. Follow-up after May 2006 indicated no out-of-control sit-
uation, supporting a return to the baseline situation. In haematology wards, signiﬁcant links were found between NIA incidence and
fungal contamination of several sites at each ward (mainly unprotected common sites). An environmental source of contamination
could be suspected, but no signiﬁcant relationship was found between NIA incidence and ongoing construction or renovation. In con-
clusion, the CUSUM test proved to be well suited for real-time monitoring of NIA and for early identiﬁcation and follow-up of an
outbreak.
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Introduction
Invasive aspergillosis (IA) is a major cause of morbidity and
mortality in immunocompromised patients, especially for
those with malignancies receiving intensive immunosuppres-
sive therapy and for those receiving allogeneic haematopoiet-
ic stem cell transplants (HSCTs) or solid organ transplants
[1,2]. In a proportion of cases, it is suspected that IA is
acquired during hospitalization, by airborne transmission
from an environmental source of contamination [3–5].
Because of this potential risk, healthcare institutions admit-
ting patients at risk for aspergillosis have established close
monitoring of cases for the early identiﬁcation of any situa-
tion that could indicate an increasing incidence of IA. How-
ever, except in cases of evident outbreak, the number of
cases is subject to natural variation, making difﬁcult the
assessment of a signiﬁcant change from a baseline-controlled
situation. For this reason, we propose the use of cumulative
sum methodology (CUSUM) [6] for such monitoring. The
principle of CUSUM charts was initially developed for indus-
trial quality control, and has already proved to be valuable in
epidemiological surveillance [7,8], including that of hospital-
acquired infections. As compared with other quality control
charts used in the medical domain, CUSUM methodology
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offers both a simple formulation and an intuitive representa-
tion [9], allowing early detection of small but persistent
changes [10–13].
In this study, CUSUM methodology was developed and
applied to the analysis of IA incidence over a 5-year period
at Saint-Louis hospital (Paris, France), allowing early detec-
tion and follow-up of an Aspergillus outbreak.
Materials and Methods
Data collection was monitored by the Aspergillus Study
Group (ASG) of the hospital, which is in charge of the
monthly recording of cases of IA from all hospital wards and
classiﬁcation of cases according to the Mycoses Study
Group/European Organization for Research and Treatment
of Cancer criteria for diagnosis [14]. For each case of proven
or probable IA, infection was assumed to be hospital-
acquired if the patient had no clinical, biological or radiologi-
cal signs of IA at admission; infection was considered to be
non-hospital-acquired if the patient had a previous history of
aspergillosis and/or signs of aspergillosis at admission. During
the study period, no routine antimould prophylaxis was
administered.
Incidence rates of hospital-acquired invasive aspergillosis,
i.e. nosocomial IA (NIA), were estimated for four groups of
patients with haematological disorders: allogeneic HSCT
(group 1) or autologous HSCT (group 2) recipients, patients
who had been treated for acute leukaemia with standard or
high-dose chemotherapy for the induction and consolidation
phases (group 3), and patients presenting other lymphoprolif-
erative or myeloproliferative disorders treated with high-
dose chemotherapy (group 4). To compute numbers of
patient-days at risk, dates of hospital stay of >24 h for
patients with given haematological disorders were extracted
from the hospital medical information system database.
Fungal monitoring of the environment was performed
once every 3 weeks in the HSCT, adult haematology and
paediatric haematology units from March 2002 to December
2006. Air samples (250 L) and surface swab samples were
collected in patient rooms provided with HEPA-ﬁltered air,
or conventional rooms supplied with air from the central
ventilation system and in common rooms of the wards
(nurse station, staff room, and corridors), as previously
described [15]. Mould genus and Aspergillus species were
identiﬁed on the basis of macroscopic and microscopic
aspects, with differentiation of the most common pathogenic
species of Aspergillus (‘Aspergillus’ hereafter) and other
moulds. Results were expressed both qualitatively (i.e. pres-
ence or absence of fungi) and quantitatively by the number
of CFUs per sample for air, and by the number of positive
samples/number of collected samples ratio in each site of the
ward for surface samples.
In order to estimate the potential consequences of ongo-
ing construction or renovation on the incidence of aspergil-
losis, we scored the risk of fungal contamination of the
environment in relation to each type of work. We used a
semiquantitative scale adapted from Berthelot et al. [16],
with four levels of risk according to the type and location of
work: level 1 for outdoor work at a distance from the main
hospital building; level 2 for heavy work indoors but outside
the ward building, or light work within the ward building but
outside the haematology units; level 3 for light indoor work
in the haematology units or heavy indoor work outside the
haematology units; and level 4 for heavy indoor work in the
haematology units. For each work operation, a cumulative
score was calculated by multiplying the estimated risk level
by the number of working days. Cumulative scores for all
hospital works were recorded monthly.
Statistical analysis
All analyses were performed using R 2.6.2 statistical software
[17]. The monthly rates of NIA were monitored using
CUSUM test methodology [6,12,18]. This test computes, at
each month n, a score Tn deﬁned by Tn ¼ maxð0; Tn1 þWnÞ
where T0 = 0 and Wn is the log-likelihood ratio sample
weight. This weight is a measure of the deviation of the
observed count from the target or expected count. At each
month n, the CUSUM then tests the null hypothesis: ‘the pro-
cess is in control’ (i.e. the incidence of NIA is at an acceptable
level) against the alternative hypothesis: ‘the process is out of
control’ (i.e. the incidence of NIA has reached an unaccept-
able level). The null hypothesis is rejected when the CUSUM
score crosses a predeﬁned limit. We used the CUSUM test
for count data, with the sample weight computed as
Wn ¼ Xn  ðk1  k0Þ=flogðk1Þ  logðk0Þg [10] where Xn is
the NIA count for month n, and k0 and k1 are the mean
monthly numbers of NIA cases expected if the process is in
control (null hypothesis) or out of control (alternative
hypothesis), respectively. We estimated the acceptable level
of NIA incidence, k0, as the average of monthly NIA counts
recorded in a reference period, between January 2002 and
December 2004. We designed the CUSUM test to detect a
two-fold increase in NIA incidence (relative risk of 2) with a
probability of 84% within 6 months of surveillance; during the
same period, the probability of false alarm was 20%. If the
CUSUM test detected an unacceptable level for the incidence
of NIA, the learning-curve (LC)-CUSUM was used [19]. In
this analysis, the hypotheses were reversed, and we wished
to test for a decrease in the monthly incidence from the out-
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of-control situation (k1) to the in-control situation (k0). If the
situation was considered to have normalized, we switched
again to the classic monitoring as described earlier.
The relationship between fungal contamination and the
incidence of NIA was estimated and tested using time-series
methods. Lagged regression with potentially autocorrelated
errors was used as previously described [15,20]. The hypoth-
eses tested were the existence of a signiﬁcant link between
NIA incidence at month n and environmental contamination
at time n, as well as 1 month and 2 months before. Regres-
sions between NIA incidence at month n and forward time-
lagged environmental contamination at months n + 1 and
n + 2 were also estimated as a control. Combining the
two lagged regressions allows to consider that a signiﬁcant
link for a deﬁned period of time preceding NIA with no sig-
niﬁcant forward link supports a causal effect between fungal
contamination and the incidence of NIA. Results were
expressed by giving the p-value of the t-test of the regression
parameter at 0 for each environmental contamination; p-val-
ues of <0.05 were regarded as indicating statistical signiﬁ-
cance.
The relationship between cumulative risk scores and inci-
dence of NIA was analysed using the same method.
Results
Between January 2002 and December 2006, 81 cases of NIA
(15 proven; 66 probable) were recorded. Most cases were
observed in the haematology departments, mainly the HSCT
unit and adult haematology (Table 1). Most patients had
underlying haematological disorders, including acute myeloid
leukaemia (22), non-Hodgkin’s lymphoma (15), acute lympho-
blastic leukaemia (9), myeloma (7), chronic lymphocytic leu-
kaemia (6), myelodysplasia (5), chronic myeloid leukaemia
(4), Fanconi’s anaemia (4), idiopathic aplastic anaemia (3),
Waldenstro¨m’s macroglobulinaemia (2), and Hodgkin’s lym-
phoma (1). Ten patients were infected with human immuno-
deﬁciency virus. Twenty-six patients were allogeneic HSCT
recipients.
CUSUM follow-up of NIA incidence
The CUSUM test for analysis of incidence was set up from
NIA counts recorded retrospectively between January 2002
and December 2004 (reference period). Beginning in January
2005, it was applied prospectively on a monthly basis.
Despite month-to-month variations in the number of cases,
CUSUM analysis showed no signiﬁcant deviation from the
expected monthly number of cases between January 2002
and August 2005 (Fig. 1). In September 2005, the CUSUM
crossed the decision limit, i.e. identiﬁed a signiﬁcant increase
in the risk of NIA as compared with the reference period
(see Doc. S1 for CUSUM calculation).
The monitoring was then switched to LC-CUSUM to test
for a decrease in the monthly incidence. Up to April 2006,
the LC-CUSUM stayed over the limit, indicating that the inci-
dence of NIA remained at an unacceptable level, whereas it
identiﬁed a signiﬁcant decrease in May 2006. Follow-up using
the classic CUSUM test from May 2006 onwards indicated
no out-of-control situation, thus supporting the hypothesis
of a return to the baseline situation. The increased incidence
during the outbreak period, as compared with the non-out-
break periods of 2005 and 2006, was observed in different
categories of patients, particularly in those with acute leukae-
mia and in allogeneic and autologous HSCT recipients
(Table 2).
Outbreak investigation and management
During the outbreak period (September 2005 to April 2006),
24 cases of NIA (four proven and 20 probable) were
recorded. Aspergillus was cultured in 11 cases, yielding Asper-
gillus fumigatus in nine cases, Aspergillus nidulans in one case,
and a co-infection with A. fumigatus and Aspergillus ﬂavus in
one case. Cases were distributed in seven different wards,
with no cluster of cases in a deﬁned ward (Fig. 2).
Following CUSUM alert, several audits were conducted in
wards admitting patients at risk of IA, in order to check
compliance with the preventive measures and policies that
are routinely implemented in our hospital to protect the
wards from fungal contamination [15], including speciﬁc pro-
cedures during construction/renovation [21–23]. A reinforce-
ment of cleaning procedures was requested, and in-room air
pressures, air-handling systems, air-supply ducts and ﬁlters
TABLE 1. Distribution of cases of nosocomial invasive
aspergillosis in Saint-Louis hospital from January 2002 to
December 2006
Years
Number of cases of nosocomial
invasive aspergillosis
Total2002 2003 2004 2005 2006
Haematology department
HSCT unit 3 5 2 7 7 24
Adult haematology 4 2 4 7 2 19
Paediatric haematology 2 1 1 0 3 7
Oncology unit 0 1 0 0 1 2
Immunohaematology A 1 0 2 3 2 8
Immunohaematology B 3 4 1 3 1 12
Other departments
ICU 0 1 2 0 1 4
Infectious diseases 0 0 0 2 1 3
Other units 0 0 0 0 2 2
Total 13 14 12 22 20 81
HSCT, haematopoietic stem cell transplant; ICU, intensive-care unit.
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were checked. No recommendation for chemoprophylaxis
was given.
We examined the relationships between fungal contamina-
tion and incidence of NIA in the HSCT and the adult and
paediatric haematology wards, where 16 cases of NIA were
observed during the outbreak. In this period, 256 air and
952 surface samples were collected. Positivity rates of fungal
cultures from air samples ranged from 6.3% in HEPA rooms
to 45.9% in common rooms. Positivity rates of fungal cul-
tures from surface samples ranged from 13.7% in HEPA
rooms to 38.9% in common rooms. Aspergillus was found in
1.1% of samples from HEPA rooms and 4.6% of samples
from common rooms.
A signiﬁcant unidirectional link was found between the
incidence of NIA and the degree of contamination by Asper-
gillus in the air of the common rooms of the paediatric hae-
matology ward (p 0.025). Other links that remained
signiﬁcant over lagged time periods after NIA episodes were
found for Aspergillus contamination of surfaces in the com-
mon rooms of the HSCT unit (p 0.004), contamination by
FIG. 1. Distribution over time of cases of
nosocomial invasive aspergillosis (NIA) at
Saint-Louis hospital between January 2002
and December 2006. (a) Monthly report
of individual cases. (b) Cumulative sums
(CUSUM) and learning-curve (LC)-CUSUM
analysis of incidence. Grey lines denote
retrospective CUSUM analysis of the ref-
erence period. Black lines denote prospec-
tive surveillance. Horizontal dashed/dotted
lines represent the test limits.
TABLE 2. Incidence rates of nosocomial invasive aspergillosis (NIA) and relative risk during the period of the outbreak
situation
Patient group
Baseline situation (2005–2006 except for out-
break period)
Outbreak period (September 2005 to April
2006)
Number of
patients
Incidence of
NIA per 1000
patient-days (95% CI)
Number of
patients
Relative risk of
NIA as compared
with baseline (95% CI)
Allogeneic HSCT 341a 0.43 (0.19–0.98) 202a 3.20 (1.13–9.12)
Autologous HSCT 269a 0.15 (0.02–1.11) 144a 4.25 (0.37–48.2)
Acute leukaemia 476 0.23 (0.09–0.55) 279 3.38 (1.02–11.2)
Other haematological malignancies 1401 0.19 (0.08–0.43) 745 0.90 (0.18–4.53)
Test for heterogeneity of relative risks: p 0.48
All patients 2487 0.24 (0.15–0.39) 1370 2.68 (1.40–5.15)
HSCT, haematopoietic stem cell transplant.
aAs HSCT recipients are considered to be at permanent higher risk for invasive aspergillosis after grafting, this number includes HSCT recipients grafted during the study
period and those previously grafted who were readmitted during the study period.
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other moulds on surfaces in the HSCT unit (p 0.038 under
ﬂow in HEPA laminar airﬂow rooms; p 0.001 in common
sites), the adult haematology ward (p 0.023 in common sites)
and the paediatric haematology ward (p 0.004 out of ﬂow in
HEPA laminar airﬂow rooms).
We examined the occurrence of construction or renova-
tion work in or around the hospital, before and at the time
of the outbreak period. Between 2003 and 2006, we
recorded an increasing number of ‘at-risk’ constructions or
renovations in the hospital, ranging from 93 in 2003 and
2004 to 136 in 2005 and 147 in 2006, with cumulative risk
scores of 1612, 1942, 3155, and 3398, respectively. Each
project had been anticipated, and the ASG had checked the
application of protective and preventive measures [21–23].
Before and during the outbreak, no failure in the application
of the recommended preventive measures was recorded.
Using a regression model for time-series data, we found no
relationship between counts of incident NIA cases at month
n and risk score values at n, n ) 1 or n ) 2 months, and no
relationship between scores of ongoing constructions or ren-
ovations and fungal contamination of air or surfaces.
Discussion
Between January 2002 and December 2006, 81 cases of NIA
were diagnosed at our institution. As the number of cases
ranged between zero and ﬁve per month, the epidemiologi-
cal interpretation of the case monitoring was often puzzling,
balancing between the risk of misinterpreting an increased
number of cases as an outbreak where it was only due to
hazard variation, or a moderate change as a ‘normal situa-
tion’ where it might have been the early phase of an out-
break.
The use of the CUSUM test proved helpful in such inter-
pretation, allowing clear discrimination between three dis-
tinct periods: ﬁrst, a controlled situation during which the
CUSUM analysis of NIA incidence showed no signiﬁcant
deviation from the expected monthly number of cases; sec-
ond, a period during which the CUSUM and LC-CUSUM
tests identiﬁed an ongoing outbreak involving 24 patients;
and third, a return to the baseline situation and controlled
process. During the outbreak, cases were observed in dis-
tinct categories of immunocompromised patients hospitalized
in seven separate wards located at different levels of the
hospital, suggesting a diffuse environmental source of con-
tamination. Time-series analysis in three haematology wards
showed signiﬁcant links between fungal contamination of the
environment (mainly in unprotected common sites of the
wards) and the incidence of NIA, as we previously reported
in our hospital [15]. These results also suggest that, in addi-
tion to the demonstration of Aspergillus in the environment,
the detection of other moulds could be an indirect indicator
of risk, as their presence suggests a lack of effective ﬁltration
or cleaning, poor compliance with protective measures, and/
or the existence of a favourable fungal biotope in the ward
[24–26].
Scoring each hospital renovation or building work and
using a regression model for time-series data, we found no
correlation between the number of cases of NIA in a deﬁned
month and the risk score of the ongoing or preceding
months. We also checked that there was no change in the
central ventilation system of the hospital before or during the
outbreak period. Water was considered to be an improbable
source of contamination, as tap water has been rarely found
to be contaminated by Aspergillus in France and in our hospital
[27]. Food could have been another potential source of con-
tamination [28], but since 2000, strict recommendations have
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been given in our hospital to avoid, or to peel or disinfect,
fruits that are potentially contaminated by Aspergillus.
We also examined the score of the audits of Aspergillus
control policies in haematology wards, which have been per-
formed every 3 months since 2003 under the supervision of
the ASG of the hospital. Overall, audit scores indicated a
high level of compliance, with no signiﬁcant change before
the outbreak (data not shown).
In conclusion, we suspected an environmental, but not
deﬁned, source of contamination. Despite this uncertainty,
we consider that environmental protection and repeated
cleaning of wards remain the mainstay of prevention of NIA.
Our data also show that a statistical tool that is well adapted
for rare events and moderate changes, such as CUSUM, is
appropriate for a prospective follow-up of NIA and early
identiﬁcation of unsuspected and unpredictable outbreaks.
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